Delivery Order SPE2DB20D6035-SPE2DB25FLXSA

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,068.03 firm fixed-price delivery order is for the supply of PROGESTERONE 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) is a $8,708.80 Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567039294 PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through January 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $13,415.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567300692 PROGESTERONE 200 MG CAPSULE 100S, with an ultimate completion date of February 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPJ14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,172.54 firm fixed-price delivery order is for the supply of 4567117594 ! PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award (SPE2DB20D1004|SPE2DB25FNFBQ) from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567341588 ! PROGESTERONE 100 MG CAPSULE 100S, with a ceiling value of $1,154.08 and a completion date of February 24, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FACW1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566373390 - Progesterone 200 mg Capsule 30s, a pharmaceutical product, with a ceiling value of $3,213.43 and a completion date of November 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $13,659.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the provision of 4,566,983,122 units of Progesterone 200 mg Capsules. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $4,217.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566823701 - Progesterone 100 mg Capsule 100s, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FANZ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,928.69 Firm Fixed Price contract is for the delivery of Progesterone 200 mg capsules to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to AmerisourceBergen Drug Corp is a $2,968.33 firm fixed-price delivery order for 4566847711 - PROGESTERONE 100 MG CAPSULE 30S. The contract has an ultimate completion date of January 7, 2025 and was awarded on January 6, 2025 by the Defense Logistics Agency (DLA). AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the DLA. The company holds a...
  • SPE2DB20D6035
    Indefinite Delivery Contract
  • SPE2DB20D6035-SPE2DB25FLXSA
    Delivery Order

This federal contract award SPE2DB20D6035|SPE2DB25FLXSA, valued at $1,512.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567322517 PROGESTERONE 100 MG CAPSULE 100S and does not have a set-aside designation.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/22/25, 8:08 PM